山东大学耳鼻喉眼学报 ›› 2022, Vol. 36 ›› Issue (4): 66-72.doi: 10.6040/j.issn.1673-3770.0.2020.263

• • 上一篇    下一篇

合并轻度出血性疾病的扁桃体和(或)腺样体切除术患儿围手术期管理

张丰珍1, 王桂香1, 魏沄沄2, 张亚梅1, 赵靖1, 王华1, 李宏彬1, 李晓丹1, 张杰1   

  1. 1. 国家儿童医学中心/首都医科大学附属北京儿童医院 耳鼻咽喉头颈外科/儿童耳鼻咽喉头颈外科疾病北京市重点实验室, 北京 100045;
    2. 北京市儿童血液病与肿瘤分子分型重点实验室/儿科学国家重点学科/首都医科大学附属北京儿童医院 血液肿瘤中心, 北京 100045
  • 发布日期:2022-07-11
  • 通讯作者: 张杰. E-mail: stzhangj@263.net
  • 基金资助:
    北京市医院管理中心“登峰”计划(DFL20191201)

Perioperative management of children with mild bleeding disorders undergoing adenotonsillectomy procedures

ZHANG Fengzhen1, WANG Guixiang1, WEI Yunyun2, ZHANG Yamei1, ZHAO Jing1, WANG Hua1, LI Hongbin1, LI Xiaodan1, ZHANG Jie1   

  1. 1. Department of Otorhinolaryngology Head & Neck Surgery / Beijing Key Laboratory for Pediatric Diseases of Otorhinolaryngology Head & Neck Surgery, National Center for Children's Health (NCCH)/ Beijing Children's Hospital, Capital Medical University, Beijing 100045, China;
    2. Beijing Key Laboratory of Pediatric Hematology Oncology / National Key Discipline of Pediatrics / Beijing Children's Hospital, Capital Medical University Hematology Oncology Center, Beijing 100045, China
  • Published:2022-07-11

摘要: 目的 探讨合并轻度出血性疾病并接受扁桃体和(或)腺样体手术的患者围手术期处理方案,提高围手术期安全。 方法 回顾分析6例合并诊断为轻度出血性疾病并行扁桃体和(或)腺样体手术患者资料。收集患者的基本信息、出血风险评估、手术方案、围术期控制出血策略等,结合文献复习分析此类患者的诊疗要点。 结果 6例患者凝血情况:血友病A FVIII:C 4.8%, APTT 57.7s; 血友病B:FIX:C 4.2%, APTT 59.3s; 血友病B FIX:C 5.9%, APTT 57.2s; FIX:C 64.3%, APTT 52.3s; FVII:C 73.3%; FX:C 66.2%; FIX:C 58.4%; APTT 44s; APTT 35s;PLT 102×109/L。3例血友病患者给予凝血因子替代治疗+抗纤溶治疗,2例凝血功能障碍患者给予新鲜冰冻血浆治疗,免疫性血小板减少患者治疗无特殊。在血液科、麻醉科、供血科配合下6例患者顺利完成腺样体扁桃体手术,手术的平均手术时间&平均出血量(血友病63.3 min & 16.7 mL,凝血功能障碍47.5 min & 10 mL,血小板减少15 min & 5 mL)。术后2例血友病(33.3%)患者在术后第4~7 d有轻度扁桃体窝渗血,输注新鲜冰冻血浆后未再发现渗血,余患者均无术后出血。血友病患者平均住院时间13.3 d,其他患者住院时间6 d,均痊愈出院,出院后1个月随访无出血。 结论 对于合并轻度出血性疾病患者行腺扁桃体切除手术,围手术期管理需要多学科协作,做好控制出血策略,手术安全可行并能达到预期手术效果。同时血友病患者围手术期抗纤溶治疗应至少7~14 d。对于凝血功能障碍患者可延长住院时间至1周,血友病患者延长至2周至伤口愈合。

关键词: 儿童, 腺样体扁桃体切除术, 轻度出血性疾病, 围手术管理, 出血

Abstract: Objective To explore the perioperative management of children with mild bleeding disorders who underwent tonsil and/or adenoid surgery, and to improve the perioperative safety of such cases in the future. Methods We conducted a retrospective analysis of six children with bleeding disorders who underwent tonsil and/or adenoid surgery in our hospital. We collected information on their diagnosis and treatment plans, bleeding risk assessments, surgical plans, and perioperative bleeding control strategies. We also analyzed the key points of diagnosis and treatment of such cases through a literature review. Results The results for the hemagglutination test of the six children were as follows: hemophilia A FVIII: C 4.8%; APTT 57.7 s, hemophilia B FIX: C 4.2%; APTT 59.3 s, hemophilia B FIX: C 5.9%; APTT 57.2 s, FIX: C 64.3%; APTT 52.3 s, FVII: C 73.3%; FX: C 66.2%; FIX: C 58.4%; APTT 44 s, APTT 35s; PLT 102×109/L. The children with hemophilia were treated with factor replacement and antifibrinolytic therapy, while the two children with coagulopathies were treated with fresh frozen plasma. There was no specific treatment for the child with immune-mediated thrombocytopenia. All six children completed tonsil and/or adenoid surgery successfully with the close cooperation of the hematology, anesthesiology, and blood supply departments. The mean operation time and average bleeding volume were 63.3 min and 16.7 mL for the hemophilia cases, 47.5 min and 10 mL for the coagulopathy cases, and 15 min and 5 mL for the child with platelet reduction. During the perioperative period the coagulation function, coagulation factor activity, inhibitor concentration, and platelet function were monitored. Different replacement treatments and anti-fibrinolytic therapies were given for different reasons. Two patients with hemophilia(33.3%)had mild tonsil hemorrhage during the first 4-7 days of their postoperative hospitalization stay. And no bleeding occurred after the transfusion of fresh frozen plasma. However, the remaining children did not show bleeding. The average length of hospitalization for children with hemophilia was 13.3 days, while the other children were hospitalized for 6 days. The patients all healed well and were discharged, and no bleeding was noted during the 1-month follow-up period. Conclusion Children with mild bleeding disorders who need to undergo tonsil and/or adenoid surgery require multi-disciplinary cooperation, and good bleeding control strategies during the perioperative period. The operation is safe and feasible for these cases. However, perioperative antifibrinolytic therapy should be continued for at least 7-14 days. The hospital stay should also be extended to 1 week for children with mild coagulation dysfunction and up to 2 weeks for cases of hemophilia to ensure the wounds are fully healed.

Key words: Children, Adenotonsillectomy, Mild bleeding disorders, Perioperative management, Blood

中图分类号: 

  • R765.9
[1] Krishna P, Lee D. Post-tonsillectomy bleeding: a meta-analysis[J]. Laryngoscope, 2001, 111(8): 1358-1361. doi:10.1097/00005537-200108000-00008.
[2] Windfuhr JP, Chen YS, Remmert S. Hemorrhage following tonsillectomy and adenoidectomy in 15, 218 patients[J]. Otolaryngol Head Neck Surg, 2005, 132(2): 281-286. doi: 10.1016/j.otohns.2004.09.007.
[3] Peyvandi F, di Michele D, Bolton-Maggs PHB, et al. Classification of rare bleeding disorders(RBDs)based on the association between coagulant factor activity and clinical bleeding severity[J]. J Thromb Haemost, 2012, 10(9): 1938-1943. doi:10.1111/j.1538-7836.2012.04844.x.
[4] Boender J, Kruip MJHA, Leebeek FWG. A diagnostic approach to mild bleeding disorders[J]. J Thromb Haemost, 2016, 14(8): 1507-1516. doi:10.1111/jth.13368.
[5] Hussein HK, Nicolson P, Fordwor K, et al. Mild bleeding disorders: what every clinician should know[J]. Br J Hosp Med, 2017, 78(12): 684-710. doi:10.12968/hmed.2017.78.12.684.
[6] 丁秋兰, 王学锋, 王鸿利, 等. 血友病诊断和治疗的专家共识: 血友病的规范化诊断[J]. 临床血液学杂志, 2010, 23(1): 49-53. doi: CNKI:SUN:LCXZ.0.2010-01-026
[7] Kang J, Brodsky L, Danziger I, et al. Coagulation profile as a predictor for post-tonsillectomy and adenoidectomy(T + A)hemorrhage[J]. Int J Pediatr Otorhinolaryngol, 1994, 28(2/3): 157-165. doi:10.1016/0165-5876(94)90007-8.
[8] Prim MP, de Diego JI, Jimenez-Yuste V, et al. Analysis of the causes of immediate unanticipated bleeding after pediatric adenotonsillectomy[J]. Int J Pediatr Otorhinolaryngol, 2003, 67(4): 341-344. doi:10.1016/s0165-5876(02)00396-8.
[9] Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia[J]. Haemophilia, 2013, 19(1): 1-47. doi:10.1111/j.1365-2516.2012.02909.x.
[10] 秦晨光, 杨天虎. 腺样体肥大合并血友病A围术期麻醉处理1例[J]. 贵州医药, 2014, 38(2): 153-154. doi:10.3969/j.ISSN.1000-744X.2014.02.024.
[11] 楼文晖. 术前凝血机制障碍的常见原因及手术时机选择[J]. 中国实用外科杂志, 2010, 30(2): 88-90. doi: CNKI:SUN:ZGWK.0.2010-02-005. LOU Wenhui. Common causes of preoperative coagulation disorders and choice of optimal operation time[J]. Chinese Journal of Practical Surgery, 2010, 30(2): 88-90. doi: CNKI:SUN:ZGWK.0.2010-02-005.
[12] Aydin S, Taskin U, Altas B, et al. Post-tonsillectomy morbidities: randomised, prospective controlled clinical trial of cold dissection versus thermal welding tonsillectomy[J]. J Laryngol Otol, 2014, 128(2): 163-165. doi:10.1017/s0022215113003253.
[13] Burckardt E, Rebholz W, Allen S, et al. Predictors for hemorrhage following pediatric adenotonsillectomy[J]. Int J Pediatr Otorhinolaryngol, 2019, 117: 143-147. doi: 10.1016/j.ijporl.2018.11.029.
[14] Patel PN, Arambula AM, Wheeler AP, et al. Post-tonsillectomy hemorrhagic outcomes in children with bleeding disorders at a single institution[J]. Int J Pediatr Otorhinolaryngol, 2017, 100: 216-222. doi: 10.1016/j.ijporl.2017.07.014.
[15] Tomkinson A, Harrison W, Owens D, et al. Postoperative hemorrhage following adenoidectomy[J]. Laryngoscope, 2012, 122(6): 1246-1253. doi:10.1002/lary.23279.
[16] Walker P, Gillies D. Post-tonsillectomy hemorrhage rates: Are they technique-dependent?[J]. Otolaryngol Head Neck Surg, 2007, 136(4): 27-31. doi: 10.1016/j.otohns.2006.10.022.
[17] Venkatesan NN, Rodman RE, Mukerji SS. Post-tonsillectomy hemorrhage in children with hematological abnormalities[J]. Int J Pediatr Otorhinolaryngol, 2013, 77(6): 959-963. doi: 10.1016/j.ijporl.2013.03.017.
[18] Rodriguez KD, Sun GH, Pike F, et al. Post-tonsillectomy bleeding in children with von Willebrand disease: a single-institution experience[J]. Otolaryngol Head Neck Surg, 2010, 142(5): 715-721. doi: 10.1016/j.otohns.2010.01.029.
[19] Sun GH, Auger KA, Aliu O, et al. Posttonsillectomy hemorrhage in children with von willebrand disease or hemophilia[J]. JAMA Otolaryngol Head Neck Surg, 2013, 139(3): 245. doi:10.1001/jamaoto.2013.1821.
[20] Witmer CM, Elden L, Butler RB, et al. Incidence of bleeding complications in pediatric patients with type 1 von willebrand disease undergoing adenotonsillar procedures[J]. J Pediatr, 2009, 155(1): 68-72. doi: 10.1016/j.jpeds.2009.01.051.
[21] Warad D, Hussain FTN, Rao AN, et al. Haemorrhagic complications with adenotonsillectomy in children and young adults with bleeding disorders[J]. Haemophilia, 2015, 21(3): e151-e155. doi:10.1111/hae.12577.
[22] 中华医学会血液学分会血栓与止血学组, 中国血友病协作组. 血友病诊断与治疗中国专家共识(2013年版)[J]. 中华血液学杂志, 2013, 34(5): 461-463. doi: 10.3760/cma.j.issn.0253-2727.2013.05.020.
[23] García-Matte R, María Constanza Beltrán M, Ximena Fonseca A, et al. Management of children with inherited mild bleeding disorders undergoing adenotonsillar procedures[J]. Int J Pediatr Otorhinolaryngol, 2012, 76(2): 291-294. doi:10.1016/j.ijporl.2011.11.024.
[24] García-Matte RJ, Beltran MC, Fonseca X, et al. Uso de desmopresina en niños con disfunción plaquetaria congénita sometidos a adeno y/o amigdalectomía[J]. Acta Otorrinolaringológica Española, 2012, 63(2): 115-119. doi: 10.1016/j.otorri.2011.09.007.
[1] 刘迪,谢应恒,朱斌,马霖,关兵,王莹,曹清,焦成,严齐,孙海勇,马伟. 不同性别未成年人鼻出血与环境气象因素相关性及滞后效应[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 47-54.
[2] 朱希倩,王佳,孙祖贤,冯建秀,张梦佳,赵颖,王宏,姜敏敏. 上海市杨浦区2022—2024年6~9岁学龄儿童屈光状态分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 102-109.
[3] 宋艳玲,司元元,崔彦. 微量玻璃体切除治疗激光笔致儿童全层黄斑裂孔1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 144-147.
[4] 刘南仙,杨泽垠,韩琳,张爱英,赵宇亮,薛静,孙怡君,邵永良. 视频脑电图在儿童复发性眩晕诊断中的意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 20-25.
[5] 黄焕,华红利,邓玉琴,江承洋,王雨薇,杨星海. 儿童过敏性鼻炎、扁桃体腺样体肥大和鼻窦炎之间相关性及其对临床指导价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 34-41.
[6] 王华,张丰珍,龙婷,赵靖,李宏彬,王生才,王桂香. 后颅窝肿瘤术后儿童气管切开原因及预后转归分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 168-173.
[7] 乐冰艳,邹剑,雷蕾,文巧,钱应雪. 儿童扁桃体微生物群与免疫调节及疾病关联[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 193-200.
[8] 曾琪璎,朱华明,关建,吴红敏,叶海波,易红良. 双极电凝镊应用于治疗Shamblin Ⅲ 型颈动脉体瘤6例[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 70-76.
[9] 王尧,陈静怡,杨颖超,苏开明. 先天性纤维蛋白原缺乏症儿童的扁桃体腺样体切除病例分析1例及文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 77-80.
[10] 黄爱萍,王娟,王丽,耿江桥,王亚芳,温鑫. 儿童原发扁桃体Burkitt淋巴瘤累及上颌骨和肺1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 148-152.
[11] 刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[12] 付圣尧,陈敏,庞文会,李娜. 内镜辅助个体化手术入路治疗儿童鼻中线囊肿及瘘管[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 65-71.
[13] 郭翔,马永强,伊海金. 突发性聋磁共振检查的现状与进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 140-144.
[14] 陈丹萍,何子键,虞幼军,周晓娓. 儿童突发性聋10年住院病例的疗效及预后相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 16-22.
[15] 杨娜,柳荫,郭宝,纪尧峰,成晨,张琛,董丽娜. 高频超声在儿童鼻骨骨折闭合复位术的应用研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 41-45.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!